SGS Expands Phase I Trial Bed Capacity

Article

Company News Release

SGS Life Science Services, a division of the SGS Group, has expanded its Phase I units in Antwerp Stuivenberg hospital (Belgium) by adding 22 new hospitalization beds. The clinical pharmacology unit brings the total number of beds to 102 for Belgium, and brings SGS's global capacity to 184 beds.
More information is available in the official Media Information document (PDF 28 KB):

SGS' Life Science Services has 30 years of experience as a global contract service organization providing integrated solutions from preclinical activities to Phase I-IV trials, Bioanalytical and QC testing. With innovative study designs, optimal facilities and strong regulatory intelligence, SGS can favourably impact client's drug development timelines and decision-making.

For more information, please visit our website, www.sgs.com/CRO"

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.